01400nam a2200289 i 450099100317691970753620020503184443.0931025s1989 it ||| | ita b10468894-39ule_instEXGIL116444ExLDip.to Filol. Ling. e Lett.ita937.01Ampolo, Carmine37679Italia omnium terrarum parens :la civiltà degli Enotri, Choni, Ausoni, Sanniti, Lucani, Brettii, Sicani, Siculi, Elimi /Carmine Ampolo...[et al.]Milano :Libri Scheiwiller,1989703 p. :ill., carta geografica ripieg. ;28 cm.Antica madreItalia anticaCiviltàOrigini.b1046889421-02-1727-06-02991003176919707536LE001 AN I 81a12001000190539le001pE0.00-l- 01010.i1391215x29-10-04LE015 937 - 45912015000067876le007LE015-0305-E242.80-l- 00000.i1252589328-05-03LE008 Ist. Glott. X M 812008000470364le008-E0.00-l- 01010.i1054210327-06-02ARC 1 1641le016Fondo NencinE25.00-no 00000.i1436697613-02-07Italia omnium terrarum parens222552UNISALENTOle001le007le008le01601-01-93ma -itait 0403513nam 2200661 a 450 991078129950332120230725051815.00-309-20959-51-283-01910-897866130191030-309-15890-7(CKB)2550000000032026(EBL)3378748(SSID)ssj0000507437(PQKBManifestationID)11344055(PQKBTitleCode)TC0000507437(PQKBWorkID)10562131(PQKB)10436788(MiAaPQ)EBC3378748(Au-PeEL)EBL3378748(CaPaEBR)ebr10454969(CaONFJC)MIL301910(OCoLC)923283190(EXLCZ)99255000000003202620110414d2011 uy 0engurcn|||||||||txtccrBuilding a national framework for the establishment of regulatory science for drug development[electronic resource] workshop summary /Institute of Medicine of the National Academies ; Yeonwoo Lebovitz, Rebecca A. English, and Anne B. Claiborne, rapporteursWashington, D.C. National Academies Press20111 online resource (95 p.)"Forum on Drug Discovery, Development, and Translation, Board on Health Sciences Policy."0-309-15889-3 Includes bibliographical references.""Front Matter""; ""Reviewers""; ""Contents""; ""Figures and Boxes""; ""Acronyms""; ""Preface""; ""1 Introduction""; ""2 Defining Regulatory Science""; ""3 The Urgent Need for Regulatory Science""; ""4 Barriers to Enhanced Regulatory Science""; ""5 Potential Models for Building a Regulatory Science Infrastructure""; ""6 Challenges in Engaging the Public Policy Community""; ""7 Envisioning Successful Regulatory Science at FDA""; ""8 Considering Next Steps""; ""References""; ""Appendix A: Agenda""; ""Appendix B: Participant Biographies"""The Food and Drug Administration (FDA) is tasked with ensuring the safety and effectiveness of medicine. FDA's science base must be strong enough to make certain that regulatory decisions are based on the best scientific evidence. The IOM held a public workshop on February 26, 2010, to examine the state of regulatory science and to consider approaches for enhancing it."--Publisher's description.Pharmaceutical policyUnited StatesCongressesDrug developmentGovernment policyUnited StatesCongressesPharmaceutical industryGovernment policyUnited StatesCongressesPharmaceutical policyDrug developmentGovernment policyPharmaceutical industryGovernment policy615.1Lebovitz Yeonwoo1521511English Rebecca A1471734Claiborne Anne B1471735Institute of Medicine (U.S.).Forum on Drug Discovery, Development, and Translation.Institute of Medicine (U.S.).Board on Health Sciences Policy.Building a National Framework for the Establishment of Regulatory Science for Drug Development(2010 :Washington, D.C.)MiAaPQMiAaPQMiAaPQBOOK9910781299503321Building a national framework for the establishment of regulatory science for drug development3788760UNINA